Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vanessa Birardi"'
Autor:
Janet Thomas MD, Mina Nguyen-Driver PsyD, Heather Bausell RD, LDN, Jane Breck MD, Javier Zambrano MD, Vanessa Birardi PharmD
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 5 (2017)
Nearly half of all patients diagnosed with phenylalanine hydroxylase (PAH) deficiency, also known as phenylketonuria, are lost to follow-up (LTFU); most are adults who stopped attending clinic after the age of 18 years. To understand why adult patien
Externí odkaz:
https://doaj.org/article/63631d3eed86453ca417181d4908b9ec
Autor:
Maria Dall’Era, Kenneth Kalunian, Michael Eaddy, Augustina Ogbonnaya, Eileen Farrelly, Eric Turowski, Vanessa Birardi, Neil Solomons, Simrat Randhawa, Paola Mina-Osorio
Publikováno v:
Journal of managed carespecialty pharmacy. 29(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f88e4e23bd55a7c8b4631a9b1a62169
https://pubmed.ncbi.nlm.nih.gov/36190835
https://pubmed.ncbi.nlm.nih.gov/36190835
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Voclosporin, a novel calcineurin inhibitor, was approved by the FDA for the treatment of adults with active lupus nephritis (LN) in combination with background immunotherapy, and was successfully tested in two pivotal trials, AURA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adfd05402dde8c13c27cb0f2f06f094b
https://doi.org/10.1093/ndt/gfac108.004
https://doi.org/10.1093/ndt/gfac108.004
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d21d001b81865cd936e0208a13114a6
https://doi.org/10.1136/lupus-2021-lupus21century.32
https://doi.org/10.1136/lupus-2021-lupus21century.32
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Voclosporin is a novel calcineurin inhibitor with a favorable metabolic profile and a consistent dose-concentration relationship, potentially eliminating the need for therapeutic drug monitoring. We have previously reported the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd76827c466f44cf2cc31be257ac418
https://doi.org/10.1093/ndt/gfab121.004
https://doi.org/10.1093/ndt/gfab121.004
Autor:
Heather Bausell, Janet A. Thomas, Jane Breck, Mina Nguyen-Driver, Vanessa Birardi, Javier Zambrano
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening v.5 2017
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 5, Article number: e170015, Published: 16 MAY 2019
Journal of Inborn Errors of Metabolism and Screening, Vol 5 (2017)
Journal of Inborn Errors of Metabolism and Screening
Instituto Genética para Todos (IGPT)
instacron:IGPT
Journal of Inborn Errors of Metabolism and Screening, Volume: 5, Article number: e170015, Published: 16 MAY 2019
Journal of Inborn Errors of Metabolism and Screening, Vol 5 (2017)
Nearly half of all patients diagnosed with phenylalanine hydroxylase (PAH) deficiency, also known as phenylketonuria, are lost to follow-up (LTFU); most are adults who stopped attending clinic after the age of 18 years. To understand why adult patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::533424852cd65ae4f6e8f7a8137f3e74
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942017000100403
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942017000100403
Publikováno v:
Health and Quality of Life Outcomes
Background Phenylketonuria (PKU) is a rare genetic disorder caused by a defect in the metabolism of phenylalanine (PHE) resulting in elevated blood and brain PHE levels, and leading to cognitive, emotional, and psychosocial problems. The phenylketonu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6a8dd23c87223d36c102c50d164ff3
https://doi.org/10.1186/s12955-017-0620-1
https://doi.org/10.1186/s12955-017-0620-1